āĻšā§āĻŽBVNRY âĸ OTCMKTS
add
Bavarian Nordic A/S - ADR
ā§§ā§Ļ.ā§Ēā§Ģ$
ā§§ā§ āĻāĻĒā§āĻ°āĻŋ, ā§Ž:ā§§ā§Ļ:ā§Ļā§Ļ PM GMT -ā§Ē · USD · OTCMKTS · āĻĄāĻŋāĻ¸āĻā§āĻ˛ā§āĻŽāĻžāĻ°
āĻ¸ā§āĻāĻāĻŽāĻžāĻ°ā§āĻāĻŋāĻ¨ āĻ¯ā§āĻā§āĻ¤āĻ°āĻžāĻˇā§āĻā§āĻ°-āĻ āĻ¤āĻžāĻ˛āĻŋāĻāĻžāĻā§āĻā§āĻ¤ āĻ¸āĻŋāĻāĻŋāĻāĻ°āĻŋāĻāĻŋ
āĻāĻžāĻ˛ āĻļā§āĻˇ āĻ¯ā§ āĻĻāĻžāĻŽā§ āĻāĻŋāĻ˛
ā§§ā§Ļ.ā§Ēā§§$
āĻ¸āĻžāĻ°āĻž āĻĻāĻŋāĻ¨ā§āĻ° āĻā§āĻ°ā§āĻĄāĻŋāĻā§ā§ āĻ¸ā§āĻāĻā§āĻ° āĻĻāĻžāĻŽā§āĻ° āĻāĻ āĻž āĻ¨āĻžāĻŽāĻžāĻ° āĻ°ā§āĻā§āĻ
ā§§ā§Ļ.ā§Ēā§Š$ - ā§§ā§Ļ.ā§Ŧā§§$
āĻ¸āĻžāĻ°āĻž āĻŦāĻāĻ°ā§āĻ° āĻ°ā§āĻā§āĻ
ā§.ā§Šā§§$ - ā§§ā§Š.ā§Ļā§Ļ$
āĻŽāĻžāĻ°ā§āĻā§āĻ āĻā§āĻ¯āĻžāĻĒ
ā§¨ā§Ģā§Ļ.ā§§ā§§Â āĻā§ USD
āĻāĻĄāĻŧ āĻāĻ˛āĻŋāĻāĻŽ
ā§Ē.ā§Ģā§¨Â āĻšāĻž
P/E āĻ
āĻ¨ā§āĻĒāĻžāĻ¤
ā§§ā§§.ā§¨ā§Ž
āĻ˛āĻā§āĻ¯āĻžāĻāĻļ āĻĒā§āĻ°āĻĻāĻžāĻ¨
-
āĻŦāĻžāĻāĻžāĻ° āĻ¸āĻāĻŦāĻžāĻĻ
āĻĢāĻžāĻāĻ¨āĻžāĻ¨ā§āĻ¸āĻŋā§āĻžāĻ˛ āĻĒāĻžāĻ°āĻĢāĻ°ā§āĻŽā§āĻ¯āĻžāĻ¨ā§āĻ¸
āĻā§ā§āĻ° āĻ¸ā§āĻā§āĻāĻŽā§āĻ¨ā§āĻ
āĻāĻĒāĻžāĻ°ā§āĻāĻ¨
āĻ¨ā§āĻ āĻāĻ¨āĻāĻžāĻŽ
| (DKK) | āĻĄāĻŋāĻ¸ā§ ā§¨ā§Ļā§¨ā§Ģinfo | Y/Y āĻĒāĻ°āĻŋāĻŦāĻ°ā§āĻ¤āĻ¨ |
|---|---|---|
āĻāĻĒāĻžāĻ°ā§āĻāĻ¨ | ā§§ā§Ēā§Ģ.ā§§ā§Ļ āĻā§ | -ā§Šā§Ļ.ā§ā§Ļ% |
āĻŦā§āĻ¯āĻŦāĻ¸āĻž āĻāĻžāĻ˛āĻžāĻ¨ā§āĻ° āĻāĻ°āĻ | ā§Ģā§Š.ā§Šā§¯Â āĻā§ | ā§¨ā§Ģ.ā§¨ā§Ē% |
āĻ¨ā§āĻ āĻāĻ¨āĻāĻžāĻŽ | -ā§¨ā§¯.ā§Žā§ŽÂ āĻā§ | -ā§§ā§Šā§Ž.ā§ā§Ŧ% |
āĻ¨ā§āĻ āĻĒā§āĻ°āĻĢāĻŋāĻ āĻŽāĻžāĻ°ā§āĻāĻŋāĻ¨ | -ā§¨ā§Ļ.ā§Ģā§¯ | -ā§§ā§Ģā§Ģ.ā§¯ā§Ē% |
āĻļā§ā§āĻžāĻ° āĻĒā§āĻ°āĻ¤āĻŋ āĻāĻĒāĻžāĻ°ā§āĻāĻ¨ | -ā§Š.ā§Šā§Ļ | -ā§§ā§Šā§Š.ā§Šā§Š% |
EBITDA | ā§§ā§Ŧ.ā§Ŧā§ŽÂ āĻā§ | -ā§Žā§§.ā§Ģā§Ž% |
āĻĒā§āĻ°āĻ¯ā§āĻā§āĻ¯ āĻā§āĻ¯āĻžāĻā§āĻ¸ā§āĻ° āĻšāĻžāĻ° | ā§§,ā§§ā§Ģā§¯.ā§Žā§Ŧ% | â |
āĻŦā§āĻ¯āĻžāĻ˛ā§āĻ¨ā§āĻ¸ āĻļāĻŋāĻ
āĻŽā§āĻ āĻ¸āĻŽā§āĻĒāĻĻ
āĻŽā§āĻ āĻĻāĻžā§
| (DKK) | āĻĄāĻŋāĻ¸ā§ ā§¨ā§Ļā§¨ā§Ģinfo | Y/Y āĻĒāĻ°āĻŋāĻŦāĻ°ā§āĻ¤āĻ¨ |
|---|---|---|
āĻā§āĻ¯āĻžāĻļ āĻ āĻāĻŽ āĻ¸āĻŽā§ā§āĻ° āĻŦāĻŋāĻ¨āĻŋā§ā§āĻ | ā§Šā§Šā§Ē.ā§Šā§ŽÂ āĻā§ | ā§Ģā§Š.ā§Ŧā§Ž% |
āĻŽā§āĻ āĻ¸āĻŽā§āĻĒāĻĻ | ā§§.ā§Ģā§ĻāĻļāĻ¤Â āĻā§ | ā§Š.ā§Žā§§% |
āĻŽā§āĻ āĻĻāĻžā§ | ā§¨ā§Ļā§Ž.ā§Ēā§Ģ āĻā§ | -ā§Šā§Ļ.ā§Ēā§Ŧ% |
āĻŽā§āĻ āĻāĻā§āĻāĻāĻŋ | ā§§.ā§¨ā§¯āĻļāĻ¤Â āĻā§ | â |
āĻāĻāĻāĻ¸ā§āĻā§āĻ¯āĻžāĻ¨ā§āĻĄāĻŋāĻ āĻļā§ā§āĻžāĻ° | ā§.ā§Žā§ŠÂ āĻā§ | â |
āĻĒā§āĻ°āĻžāĻāĻ¸ āĻā§ āĻŦā§āĻ āĻ°ā§āĻļāĻŋāĻ | ā§Ļ.ā§Ļā§Ŧ | â |
āĻ¸āĻŽā§āĻĒāĻĻ āĻĨā§āĻā§ āĻā§ | ā§Ļ.ā§Žā§Ē% | â |
āĻŽā§āĻ˛āĻ§āĻ¨ āĻĨā§āĻā§ āĻā§ | ā§Ļ.ā§¯ā§Ŧ% | â |
āĻā§āĻ¯āĻžāĻļ āĻĢā§āĻ˛ā§
āĻ¨āĻāĻĻā§ āĻŽā§āĻ āĻĒāĻ°āĻŋāĻŦāĻ°ā§āĻ¤āĻ¨
| (DKK) | āĻĄāĻŋāĻ¸ā§ ā§¨ā§Ļā§¨ā§Ģinfo | Y/Y āĻĒāĻ°āĻŋāĻŦāĻ°ā§āĻ¤āĻ¨ |
|---|---|---|
āĻ¨ā§āĻ āĻāĻ¨āĻāĻžāĻŽ | -ā§¨ā§¯.ā§Žā§ŽÂ āĻā§ | -ā§§ā§Šā§Ž.ā§ā§Ŧ% |
āĻ
āĻĒāĻžāĻ°ā§āĻļāĻ¨ āĻĨā§āĻā§ āĻĒāĻžāĻā§āĻž āĻā§āĻ¯āĻžāĻļ | ā§Ģā§Ē.ā§Ģā§Ļ āĻā§ | -ā§Ēā§¨.ā§¯ā§Ģ% |
āĻŦāĻŋāĻ¨āĻŋā§ā§āĻ āĻĨā§āĻā§ āĻĒā§āĻ°āĻžāĻĒā§āĻ¤ āĻā§āĻ¯āĻžāĻļ | -ā§¯ā§§.ā§Šā§§Â āĻā§ | -ā§§ā§Žā§Ļ.ā§Ģā§¯% |
āĻĢāĻžāĻāĻ¨ā§āĻ¯āĻžāĻ¨ā§āĻ¸āĻŋāĻ āĻĨā§āĻā§ āĻĒā§āĻ°āĻžāĻĒā§āĻ¤ āĻā§āĻ¯āĻžāĻļ | -ā§§.ā§Ļā§ŠÂ āĻā§ | ā§Šā§Ž.ā§¯ā§¯% |
āĻ¨āĻāĻĻā§ āĻŽā§āĻ āĻĒāĻ°āĻŋāĻŦāĻ°ā§āĻ¤āĻ¨ | -ā§Šā§.ā§Žā§Ē āĻā§ | -ā§§ā§Ŧā§Ļ.ā§Šā§Ž% |
āĻĢā§āĻ°āĻŋ āĻā§āĻ¯āĻžāĻļ āĻĢā§āĻ˛ā§ | ā§Ēā§§.ā§Ģā§ŠÂ āĻā§ | ā§§ā§Žā§Ļ.ā§Ģā§Ŧ% |
āĻ¸āĻŽā§āĻĒāĻ°ā§āĻā§
Bavarian Nordic A/S is a Danish biotechnology company focused on the development, manufacturing and commercialization of vaccines. The company is headquartered in Hellerup, Denmark, with manufacturing facilities in KvistgÃĨrd, Denmark and ThÃļrishaus near Bern, Switzerland. The company has research and development facilities in Martinsried, Germany, as well as offices in USA, Canada, and France. The company uses viral vectors and virus-like particles in its research and development.
In July 2025, the company agreed to be acquired by private equity firms Permira and Nordic Capital for 19 billion kr. However, in November, the acquisition failed to gain sufficient support from Bavarian Nordic's shareholders, leading to its termination. Wikipedia
āĻ¸āĻŋāĻāĻ
āĻ¸ā§āĻĨāĻžāĻĒāĻŋāĻ¤ āĻšā§ā§āĻā§
ā§§ āĻā§āĻ˛, ā§§ā§¯ā§¯ā§¨
āĻā§ā§āĻŦāĻ¸āĻžāĻāĻ
āĻāĻ°ā§āĻŽāĻāĻžāĻ°ā§
ā§§,ā§Ŧā§¯ā§¨
